User profiles for "author:Delphine Borgel"

Borgel Delphine

université Paris Sud
Verified email at u-psud.fr
Cited by 4815

Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of …

M Schiff, C Roda, ML Monin, A Arion, M Barth… - Journal of medical …, 2017 - jmg.bmj.com
Background Phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG) is
a multisystem inborn error of metabolism. Objectives To better characterise the natural …

International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: diagnosis, treatment and follow up

R Altassan, R Péanne, J Jaeken… - Journal of inherited …, 2019 - Wiley Online Library
Abstract Phosphomannomutase 2 (PMM2‐CDG) is the most common congenital disorder of
N‐glycosylation and is caused by a deficient PMM2 activity. The clinical presentation and …

Inflammation in deep vein thrombosis: a therapeutic target?

D Borgel, E Bianchini, D Lasne, T Pascreau, F Saller - Hematology, 2019 - Taylor & Francis
Deep vein thrombosis is a common disease associated with a variety of complications
including post-thrombotic syndrome as a late complication. It is now clear that in addition to …

Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6

S Loges, T Schmidt, M Tjwa… - Blood, The Journal …, 2010 - ashpublications.org
The transforming and tumor growth–promoting properties of Axl, a member of the Tyro3, Axl,
and Mer (TAM) family of receptor tyrosine kinases (TAMRs), are well recognized. In contrast …

Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ …

K Martin, D Borgel, N Lerolle, HB Feys… - Critical care …, 2007 - journals.lww.com
Objective: The inability to regulate the inflammatory response initiated upon infection leads
to severe sepsis, characterized by widespread microvascular injury and thrombosis, organ …

Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis

D Borgel, S Clauser, C Bornstain, I Bièche… - Critical care …, 2006 - journals.lww.com
Objective: Growth-arrest-specific protein 6 (Gas6), an intracellular protein released by
apoptotic cells, has been detected in normal plasma. As the Gas6 system has been …

Inefficacy of ultrasound-guided local injections of autologous conditioned plasma for recent epicondylitis: results of a double-blind placebo-controlled randomized …

B Montalvan, P Le Goux, S Klouche, D Borgel… - …, 2016 - academic.oup.com
Objectives. The aim was to assess the efficacy of two intra-tendinous injections of platelet-
rich plasma (PRP) on epicondylitis of recent evolution (≤ 3 months). Methods. Our study …

Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4

D Lamaa, HP Lin, L Zig, C Bauvais… - Journal of Medicinal …, 2018 - ACS Publications
Designing multitarget drugs have raised considerable interest due to their advantages in the
treatment of complex diseases such as cancer. Their design constitutes a challenge in …

Consensus guideline for the diagnosis and management of mannose phosphate isomerase‐congenital disorder of glycosylation

A Čechová, R Altassan, D Borgel… - Journal of inherited …, 2020 - Wiley Online Library
Mannose phosphate isomerase‐congenital disorder of glycosylation (MPI‐CDG) deficiency
is a rare subtype of congenital disorders of protein N‐glycosylation. It is characterised by …

TUBB 1 Mutations cause thyroid dysgenesis associated with abnormal platelet physiology

A Stoupa, F Adam, D Kariyawasam… - EMBO molecular …, 2018 - embopress.org
The genetic causes of congenital hypothyroidism due to thyroid dysgenesis (TD) remain
largely unknown. We identified three novel TUBB 1 gene mutations that co‐segregated with …